UBS Lux Equity Fund Biotech USD vs Proethos Fond

UBS Lux Equity Fund Biotech USD vs Proethos Fond

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    6

  • Number of owning funds

    1

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Proethos Fond, we have 9 holdings where Vestas is the largest holding (5.81), followed by Ormat Technologies (4.45) and First Solar (4.38).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Proethos Fond.

UBS Lux Equity Fund Biotech USD Proethos Fond
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Vestas Wind Systems A/S
Denmark
5.81 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Ormat Technologies Inc
USA
4.45 %
3. Moderna Inc
9.21 %
3. First Solar Inc
USA
4.38 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. NIBE Industrier B
Sweden
4.3 %
5. AbbVie Inc
USA
5.52 %
5. Nordex SE
Germany
3.93 %
6. Gilead Sciences Inc
USA
4.66 %
6. Enphase Energy Inc
USA
2.45 %
7. Amgen Inc
4.32 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-
10. Royalty Pharma Plc
3.28 %
-

The list of fund holdings was last updated on April 17, 2025.